| Literature DB >> 33954417 |
Christy Ciccarello1, Molly Billstein Leber2, Mandy C Leonard3, Todd Nesbit4, Mary G Petrovskis5, Emily Pherson6, Heidi A Pillen7, Celia Proctor8, Jennifer Reddan9.
Abstract
Keywords: formulary; formulary system; medication-use evaluation; pharmacoeconomics; pharmacy and therapeutics committee; quality improvement
Year: 2021 PMID: 33954417 DOI: 10.1093/ajhp/zxab080
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN: 1079-2082 Impact factor: 2.637